2-(4-methoxybenzyl)-1,3-dioxoisoindoline-5-carboxylic acid | 351996-94-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异吲哚及其衍生物
• 英文名称: 2-(4-methoxybenzyl)-1,3-dioxoisoindoline-5-carboxylic acid
• 英文别名: 2-[(4-methoxyphenyl)methyl]-1,3-dioxoisoindole-5-carboxylic acid
• CAS: 351996-94-6
• 化学式: C₁₇H₁₃NO₅
• mdl: MFCD02207583
• 分子量: 311.294
• InChiKey: JVIJCICMASYNLD-UHFFFAOYSA-N

物化性质

• 沸点：
  550.6±40.0 °C(Predicted)
• 密度：
  1.431±0.06 g/cm3(Predicted)
• 溶解度：
  >46.7 [ug/mL]

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  83.9
• 氢给体数：
  1
• 氢受体数：
  5

安全信息

• 危险等级：
  IRRITANT
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P330,P363,P501
• 危险性描述：
  H302,H312,H332

反应信息

• 作为反应物：
  描述：

  2-(4-methoxybenzyl)-1,3-dioxoisoindoline-5-carboxylic acid 在 草酰氯 、 N,N-二甲基甲酰胺 作用下， 以 二氯甲烷 为溶剂， 生成 2-(4-Methoxy-benzyl)-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid (2-piperidin-1-yl-ethyl)-amide
  参考文献：
  名称：

  Design, synthesis, and biological evaluation of 1,3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers

  摘要：

  A small molecule library of 1,3-dioxoisoindoline-5-carboxamides 4 was designed based on the pharmacophore model, synthesized and biologically evaluated as potential T-type calcium channel blockers. The most active compounds 4d and 4n show T-type calcium channel blocking activity with IC50 values of 0.93 and 0.96 mu M, respectively. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.10.042
• 作为产物：
  描述：

  4-甲氧基苄胺 、 偏苯三酸酐 以 溶剂黄146 为溶剂， 生成 2-(4-methoxybenzyl)-1,3-dioxoisoindoline-5-carboxylic acid
  参考文献：
  名称：

  Design, synthesis, and biological evaluation of 1,3-dioxoisoindoline-5-carboxamide derivatives as T-type calcium channel blockers

  摘要：

  A small molecule library of 1,3-dioxoisoindoline-5-carboxamides 4 was designed based on the pharmacophore model, synthesized and biologically evaluated as potential T-type calcium channel blockers. The most active compounds 4d and 4n show T-type calcium channel blocking activity with IC50 values of 0.93 and 0.96 mu M, respectively. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2006.10.042

文献信息

• 1,3-DIOXOISOINDOLE DERIVATIVES HAVING SELECTIVE ANTAGONISM OF T-TYPE CALCIUM CHANNEL
  申请人：Cho Yong Seo

  公开号：US20070259867A1

  公开（公告）日：2007-11-08

  The present invention relates to 1,3-dioxoisoindole derivatives of Formula (1) or pharmaceutically acceptable salts thereof, a preparation method thereof and use thereof as a T-type calcium channel antagonist, based on the fact that 1,3-dioxoisoindole derivatives of Formula (1) show selective antagonistic activity against T-type calcium channel, thus being effective in treating brain diseases, cardiac diseases and neurogenic pains: wherein R 1 is a phenyl or a benzyl group, optionally substituted with a moiety selected from the group consisting of a halogen atom, a C 1 -C 6 alkoxy, a C 1 -C 6 alkyl, and a cyano group; R 2 is a heterocyclic group selected from the group consisting of piperidinyl, pyrrolidinyl, morpholinyl, and piperazinyl groups, wherein the heterocyclic group is optionally substituted with a C 1 -C 6 alkyl group; and n is 1 or 2.

  本发明涉及公式（1）的1,3-二氧杂异吲哚衍生物或其药学上可接受的盐，其制备方法和用作T型钙通道拮抗剂的用途，基于公式（1）的1,3-二氧杂异吲哚衍生物显示出选择性拮抗T型钙通道的活性，因此对治疗脑部疾病，心脏疾病和神经痛有效。其中，R1是苯基或苄基，可选地被取代为来自卤素原子，C1-C6烷氧基，C1-C6烷基和氰基的基团中选出的一个基团；R2是选自哌啶基，吡咯烷基，吗啉基和哌嗪基的杂环基团，其中该杂环基团可选地被C1-C6烷基取代；n为1或2。
• Triazole derivative or salt thereof
  申请人：Yoshimura Seiji

  公开号：US08377923B2

  公开（公告）日：2013-02-19

  [Problem] A compound, which can be used for preventing or treating diseases, in which 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is concerned, in particular, diabetes, insulin resistance, dementia, schizophrenia and depression, is provided. [Means for Solution] It was found that a triazole derivative, in which one of the 3- and 5-positions of the triazole ring has (di)alkylmethyl or cycloalkyl, each of which is substituted with —O— (aryl or a heterocyclic group, each of which may be substituted, or lower alkylene-cycloalkyl), and the other thereof has aryl, a heterocyclic group or cycloalkyl, each of which may be substituted, or a pharmaceutically acceptable salt thereof exhibits potent 11β-HSD1 inhibitory action. From the above, the triazole derivative of the present invention can be used for preventing or treating diabetes, insulin resistance, dementia, schizophrenia and depression.

  [问题] 提供了一种可以用于预防或治疗疾病的化合物，其中涉及11β-羟基类固醇脱氢酶1型（11β-HSD1），特别是糖尿病、胰岛素抵抗、痴呆症、精神分裂症和抑郁症。 [解决方法] 发现三唑衍生物，其中三唑环的3位和5位中的一个具有（二）烷基甲基或环烷基，每个都被取代为- O-（芳基或杂环基，每个都可以被取代，或较低的烷基-环烷基），而其另一个具有芳基，杂环基或环烷基，每个都可以被取代，或其药学上可接受的盐，表现出强效的11β-HSD1抑制作用。从上述可以得出，本发明的三唑衍生物可用于预防或治疗糖尿病、胰岛素抵抗、痴呆症、精神分裂症和抑郁症。
• TRIAZOLE DERIVATIVE OR SALT THEREOF
  申请人：Astellas Pharma Inc.

  公开号：EP2298747B1

  公开（公告）日：2016-12-28
• US7319098B2
  申请人：——

  公开号：US7319098B2

  公开（公告）日：2008-01-15
• US8377923B2
  申请人：——

  公开号：US8377923B2

  公开（公告）日：2013-02-19